Description
The FDA’s Office of Science and Engineering Laboratories is seeking a supplier to provide twenty (20) new, unused, implantable‑medical‑grade primary lithium batteries (Li/SVO‑CFx chemistry) in two configurations (10 high‑rate, 10 medium‑rate). The batteries must meet detailed electrical, mechanical, and environmental specifications, be packaged and shipped in compliance with DOT/IATA hazardous‑material rules, and be delivered to the FDA facility in Silver Spring, MD. The contract is a one‑time purchase; delivery of the high‑rate set is due within 180 days of award, the medium‑rate set within 30 days, with a firm final delivery deadline of March 31 2028. The supplier must provide standard product documentation (spec sheets, SDS) at no extra charge and honor the manufacturer’s standard commercial warranty.
• Quantity: 20 batteries total (10 high‑rate, 10 medium‑rate)
• Chemistry: Lithium‑Silver‑Vanadium‑Oxide/Carbon‑Monofluoride (Li/SVO‑CFx)
• High‑rate specs: 1.70‑1.90 Ah, 3.15‑3.40 V, ≥95.3 kΩ load, 3 A pulse, ≤17 g, ≤6.5 cc, stainless‑steel case
• Medium‑rate specs: 4.80‑5.00 Ah, 3.15‑3.40 V, 9.53 kΩ load, 20 mA pulse, ≤22 g, ≤12.5 cc, titanium case
• Minimum 2‑year shelf life at delivery
• Delivery location: FDA, Building 62, Room 1216, 10903 New Hampshire Ave, Silver Spring, MD 20993
• Delivery schedule: high‑rate within 180 days, medium‑rate within 30 days of award; all must be received by 31 Mar 2028
• Documentation: specifications, safety data sheets, lot & date markings, advance shipping notice
• Warranty: supplier’s standard commercial warranty (to the maximum extent practicable)